A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Brimonidine (Primary)
- Indications Erythema
- Focus Registrational; Therapeutic Use
- Sponsors Galderma
- 10 Feb 2014 New trial record